NCT01949311 · Interventional trial
Open-label Study of Dupilumab in Patients With Atopic Dermatitis
Overall registry status Completed
Phase 3
Conditions Atopic Dermatitis
Delaware Valley sites
- Regeneron Study Site · Berlin, NJ · Camden County
- Regeneron Study Site · East Windsor, NJ · Mercer County
- Regeneron Study Site · Jenkintown, PA · Montgomery County
- Regeneron Study Site · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory